These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29132233)

  • 1. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
    Meng X; Yang B; Suen WC
    Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.
    Akarsu A; Halaçlı S; Tan Ç; Kuşkonmaz B; Küpesiz A; Çetinkaya D; Sanal Ö; Tezcan İ; Çağdaş D
    Scand J Immunol; 2022 Nov; 96(5):e13213. PubMed ID: 36808635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hyper IgM syndromes.
    Qamar N; Fuleihan RL
    Clin Rev Allergy Immunol; 2014 Apr; 46(2):120-30. PubMed ID: 23797640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
    Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
    Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
    Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects.
    Jhamnani RD; Nunes-Santos CJ; Bergerson J; Rosenzweig SD
    Front Immunol; 2018; 9():2172. PubMed ID: 30319630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
    Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
    Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity in hyper-IgM syndrome.
    Jesus AA; Duarte AJ; Oliveira JB
    J Clin Immunol; 2008 May; 28 Suppl 1():S62-6. PubMed ID: 18246414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
    Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
    J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the hyper immunoglobulin M syndromes.
    Davies EG; Thrasher AJ
    Br J Haematol; 2010 Apr; 149(2):167-80. PubMed ID: 20180797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report.
    Cicalese MP; Gerosa J; Baronio M; Montin D; Licciardi F; Soresina A; Dellepiane RM; Miano M; Baselli LA; Volpi S; Dufour C; Plebani A; Aiuti A; Lougaris V; Fousteri G
    Front Immunol; 2018; 9():1761. PubMed ID: 30131802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
    Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
    J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
    Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
    Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
    Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
    Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis.
    Lee WI; Zhu Q; Gambineri E; Jin Y; Welcher AA; Ochs HD
    J Allergy Clin Immunol; 2003 Nov; 112(5):958-64. PubMed ID: 14610488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of enteric IgA in an unimmunised mouse model of Hyper IgM syndrome derived from gut-associated secondary lymph organs even in the absence of germinal centres.
    Hernandez-Cazares F; Maqueda-Alfaro RA; Lopez-Saucedo C; Martinez-Barnetche J; Yam-Puc JC; Estrada-Parra S; Flores-Romo L; Estrada-Garcia T
    Front Cell Infect Microbiol; 2023; 13():1172021. PubMed ID: 37457961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.
    Lee WI; Torgerson TR; Schumacher MJ; Yel L; Zhu Q; Ochs HD
    Blood; 2005 Mar; 105(5):1881-90. PubMed ID: 15358621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hyper IgM syndrome--an evolving story.
    Etzioni A; Ochs HD
    Pediatr Res; 2004 Oct; 56(4):519-25. PubMed ID: 15319456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different molecular behavior of CD40 mutants causing hyper-IgM syndrome.
    Lanzi G; Ferrari S; Vihinen M; Caraffi S; Kutukculer N; Schiaffonati L; Plebani A; Notarangelo LD; Fra AM; Giliani S
    Blood; 2010 Dec; 116(26):5867-74. PubMed ID: 20702779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.
    Hubbard N; Hagin D; Sommer K; Song Y; Khan I; Clough C; Ochs HD; Rawlings DJ; Scharenberg AM; Torgerson TR
    Blood; 2016 May; 127(21):2513-22. PubMed ID: 26903548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.